ARCHIVES

Retrovirus Vaccination Is Feasible, Workshop Participants Conclude

This article is from The Cancer Letter archive.

Vol. 11 No. 18 | May 3, 1985

Download PDF Visit The Full Archive

Related Articles

Molecular target Drug Discovery Grants; Unanimously Approved

July 2, 1999

NCI renews Roswell Park’s core grant for five years.

September 26, 2003

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

March 30, 2001

Henschke Responds To Questions from The New York Times

April 29, 2011

Idaho Senator Pressure DeVita On Taking Neutron Facility

May 6, 1988

Michael Atkins Named Deputy Director at Georgetown Lombardi Cancer Center

March 2, 2012